Geode Capital Management, LLC Inovio Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.35 - $0.53 $42,149 - $63,826	120,427 Added 4.38%	2,871,445 $1.46 Million
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.58 $41,885 - $63,930	-110,225 Reduced 3.85%	2,751,018 $1.07 Million
Q2 2023 Aug 11, 2023	SELL	$0.39 - $0.94 $903,059 - $2.18 Million	-2,315,538 Reduced 44.73%	2,861,243 $1.29 Million
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $226,462 - $547,524	286,662 Added 5.86%	5,176,781 $4.24 Million
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $409,043 - $725,255	290,102 Added 6.31%	4,890,119 $7.63 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $1.06 Million - $1.78 Million	636,461 Added 16.06%	4,600,017 $7.94 Million
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $821,553 - $2.27 Million	570,523 Added 16.81%	3,963,556 $6.86 Million
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $836,331 - $1.46 Million	-281,593 Reduced 7.66%	3,393,033 $12.2 Million
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $1.75 Million - $2.62 Million	351,457 Added 10.58%	3,674,626 $18.3 Million
Q3 2021 Nov 12, 2021	SELL	$7.16 - $9.69 $2.15 Million - $2.91 Million	-300,319 Reduced 8.29%	3,323,169 $23.8 Million
Q2 2021 Aug 13, 2021	BUY	$6.23 - $10.03 $1.89 Million - $3.04 Million	302,619 Added 9.11%	3,623,488 $33.6 Million
Q1 2021 May 12, 2021	BUY	$8.81 - $16.96 $7.02 Million - $13.5 Million	796,466 Added 31.55%	3,320,869 $30.8 Million
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $1.1 Million - $1.66 Million	128,954 Added 5.38%	2,524,403 $22.3 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $2.04 Million - $5.76 Million	213,029 Added 9.76%	2,395,449 $27.8 Million
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $3.56 Million - $15.8 Million	497,957 Added 29.56%	2,182,420 $58.8 Million
Q1 2020 May 14, 2020	BUY	$2.98 - $14.09 $993,478 - $4.7 Million	333,382 Added 24.68%	1,684,463 $12.5 Million
Q4 2019 Feb 13, 2020	BUY	$1.97 - $3.72 $115,040 - $217,233	58,396 Added 4.52%	1,351,081 $4.46 Million
Q3 2019 Nov 12, 2019	BUY	$2.05 - $3.02 $190,908 - $281,240	93,126 Added 7.76%	1,292,685 $2.65 Million
Q2 2019 Aug 14, 2019	BUY	$2.29 - $4.1 $156,512 - $280,218	68,346 Added 6.04%	1,199,559 $3.53 Million
Q1 2019 May 14, 2019	BUY	$3.34 - $5.1 $424,574 - $648,301	127,118 Added 12.66%	1,131,213 $4.22 Million
Q4 2018 Feb 13, 2019	BUY	$3.89 - $6.11 $486,117 - $763,542	124,966 Added 14.21%	1,004,095 $4.02 Million
Q3 2018 Nov 13, 2018	BUY	$3.92 - $5.58 $107,372 - $152,841	27,391 Added 3.22%	879,129 $4.89 Million
Q2 2018 Aug 14, 2018	BUY	$3.88 - $5.16 $180,175 - $239,614	46,437 Added 5.77%	851,738 $3.34 Million
Q1 2018 May 15, 2018	SELL	$4.05 - $5.69 $114,720 - $161,174	-28,326 Reduced 3.4%	805,301 $3.79 Million
Q4 2017 Feb 13, 2018	BUY	$4.13 - $6.68 $326,274 - $527,726	79,001 Added 10.47%	833,627 $3.44 Million
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $916,393 - $1.09 Million	170,969 Added 29.29%	754,626 $4.78 Million
Q2 2017 Aug 14, 2017	BUY	N/A	583,657	583,657 $4.58 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $546M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account